Couples Weight Loss Program for Obesity
(BUILD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to enhance an online weight loss program for couples. The study tests strategies such as planning together, receiving feedback, and making home changes to support weight loss. It aims to identify the best combination for effective weight loss in couples. Eligible couples should have a BMI between 25-55, live together, and be comfortable using a smartphone with internet access. As an unphased trial, this study offers couples the chance to contribute to innovative weight loss solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It would be best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that behavioral weight loss (BWL) programs are generally safe and easy for participants to follow. One study on a telehealth BWL program found it practical and well-received, with participants losing a significant amount of weight without major side effects. Another review confirms that BWL treatments effectively help people manage their weight over time, with no major safety concerns reported.
The Core BWL intervention in this trial uses similar methods, aiming to help couples support each other in losing weight. Since this study does not test a new drug or device, the safety risks are minimal. Overall, participants can expect this program to be a safe way to manage weight with their partners.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring a multi-faceted approach to weight loss by involving couples in the process. Unlike traditional weight loss programs that often focus solely on the individual, this trial incorporates elements like Dyadic Action Planning and Autonomy Support Training, which encourage partners to work together and support one another. Additionally, the trial looks at modifying the home environment to make it more conducive to healthy habits. By integrating these unique components, the trial aims to uncover whether a collaborative, supportive approach can lead to more effective and sustainable weight loss outcomes.
What evidence suggests that this trial's treatments could be effective for obesity?
Research shows that behavioral weight loss (BWL) programs effectively manage obesity. In this trial, participants will receive the Core BWL Intervention, a key component across all treatment arms. Studies have found that these programs greatly improve eating habits in people who are overweight or obese, helping participants gain better control over unhealthy eating patterns. Many BWL programs include digital tools to track weight, diet, and exercise, supporting long-term weight management. Overall, BWL is a recommended method for effective weight management.26789
Are You a Good Fit for This Trial?
This trial is for married or cohabitating couples where both partners are overweight (BMI between 25-55), speak and read English, have a smartphone with internet access, an active email address, and are willing to videoconference. Both must meet the criteria to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in an online-only couples weight loss program using various strategies such as dyadic action planning, joint feedback, autonomy support training, and home environment modifications
Follow-up
Participants are monitored for weight change and other secondary outcomes such as physical activity and dietary intake
What Are the Treatments Tested in This Trial?
Interventions
- Autonomy Support Training
- Core Behavioral Weight Loss (BWL) intervention
- Dyadic Action Planning
- Home Environment Modifications
- Joint Feedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Connecticut
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator